MHIDIA AND MELNYK
with Cu(II) as usual in the presence of bicinchoninic acid (BCA).
BCA is a sensitive, stable, and highly specific reagent for Cu(I) [36].
It forms a BCA/Cu(I): 2/1 complex that absorbs strongly at 562 nm.
Thus, absorbance of the reaction mixture at 562 nm reveals the
in situformationofCu(I)species.Figure 4showsthatabsorbanceof
the reaction mixture at 562 nm increased significantly for peptides
1a and 5a but not for control peptides 1b and 5b or CuBr2/BCA
mixture without peptide. Interestingly, absorbance at 562 nm
was significantly higher for peptide 5a than for peptide 1a, in
accordance with the higher rate of cleavage observed for the
former due to the long-range effect of His residue. This experiment
showed the formation of Cu(I) species during the Cu(II)-induced
cleavageofAglypeptides(Scheme 4). Thus, thereactioncouldfirst
involve formation of type 14 or 15 complexes. A type 14 complex
was proposed as an intermediate in the reaction between 1-
phenylsemicarbazide and Cu(II) [30]. Formation of the type 15
complex can be proposed as well because similar complexes are
formed when 1,2-diacylhydrazines are reacted with Cu(II) in the
presence of a base [31]. Formation of these complexes is probably
favored by the ease of 1,2-diacylhydrazines deprotonation (pKa
10.9 for 1,2-diacetylhydrazine) [37]. By comparison, the pKa for
deprotonation of the amide group in N-methylacetamide, a model
for the peptide bond, has been estimated to 18 [38]. This pKa
explains why the biuret reaction between polypeptides and Cu(II)
is performed at high pH, typically in 0.1 M aqueous NaOH [39].
Moreover, deprotonation of the peptide bond is facilitated by
coordination of Cu(II) to the amide oxygen [40]. Precoordination
of Cu(II) to the Agly moiety might lower the pKa of hydrazine
nitrogens similarly allowing the reaction to proceed at pH 7.3
(Figure 2).
species, which could be detected using BCA as a probe. A cleavage
mechanism is proposed based on previous reports and on data
presented. Besides the usefulness of this report for those involved
in azapeptide synthesis, Agly peptides might be used as cleavage
linkers whose cleavage is triggered by the presence of Cu(II).
Acknowledgements
We are grateful to the CNRS, Universite´ de Lille Nord de France,
Institut Pasteur de Lille, IFR 142, Re´gion Nord Pas de Calais, the
European Community (FEDER), and from Cance´ropoˆle Nord-Ouest
for their financial support. We warmly thank Herve´ Drobecq for
MALDI-TOF MS and Ge´rard Montagne for NMR experiments. This
research was performed using the Chemistry Systems Biology
platform (http://csb.ibl.fr).
Supporting information
Supporting information may be found in the online version of this
article.
References
1 Gante J. Peptide and azapeptide synthesis by means of a new
N-activated amino acid derivative. Chem. Ber. 1966; 99: 1576–1579.
2 Gante J. Azapeptides. Synthesis-Stuttgart 1989; 17: 405–413.
3 Lee HJ, Park HM, Lee KB. The beta-turn scaffold of tripeptide
containing an azaphenylalanine residue. Biophys. Chem. 2007; 125:
117–126.
4 Didierjean C,DelDuca V,Benedetti E,Aubry A,Zouikri M,Marraud M,
Boussard G. X-ray structures of aza-proline-containing peptides. J.
Pept. Res. 1997; 50: 451–457.
5 Zouikri M, Vicherat A, Aubry A, Marraud M, Boussard G. Azaproline
as a beta-turn-inducer residue opposed to proline. J. Pept. Res. 1998;
52: 19–26.
6 Dutta AS, Furr BJ, Giles MB, Morley JS. Synthesis and biological
activity of alpha-azapeptides: alpha-aza-analogues of luteinizing
hormone releasing hormone. Clin. Endocrinol. (Oxf) 1976; 5: (Suppl):
291S–298S.
7 Din H, Gray CJ, Ireson JC, McDonald R. Inhibition of trypsin by t-
butyloxycarbonyl-alpha-aza-(4-aminophenyl)alanine phenyl ester.
J. Chem. Technol. Biotechnol. 1991; 50: 181–189.
8 Bondebjerg J, Fuglsang H, Valeur KR, Kaznelson DW, Hansen JA,
Pedersen RO, Krogh BO, Jensen BS, Lauritzen C, Petersen G,
Pedersen J, Naerum L. Novel semicarbazide-derived inhibitors of
human dipeptidyl peptidase I (hDPPI). Bioorg. Med. Chem. 2005; 13:
4408–4424.
9 Verhelst SH, Witte MD, Arastu-Kapur S, Fonovic M, Bogyo M. Novel
aza peptide inhibitors and active-site probes of papain-family
cysteine proteases. ChemBioChem 2006; 7: 943–950.
10 Weber D, Berger C, Eickelmann P, Antel J, Kessler H. Design of
selective peptidomimetic agonists for the human orphan receptor
BRS-3. J. Med. Chem. 2003; 46: 1918–1930.
11 Steinmetzer T, Schweinitz A, Kunzel S, Wikstrom P, Hauptmann J,
Sturzebecher J. Structure–activity relationships of new NAPAP-
analogs. J. Enzyme Inhib. Med. Chem. 2002; 17: 241–249.
12 Wipf P, Li W, Adeyeye CM, Rusnak JM, Lazo JS. Synthesis of
chemoreversible prodrugs of ara-C with variable time-release
profiles. Biological evaluation of their apoptotic activity. Bioorg.
Med. Chem. 1996; 4: 1585–1596.
The biuret complex between polypeptides and Cu(II) involves
deprotonation of four peptide bonds, resulting in the binding
of four imidic nitrogens to Cu(II) [41]. The mild experimental
conditions used in this work do not favor such complex formation
because peptides 1–5b were unable to react with Cu(II) (Figures 2
and 3). Assuming that Cu(II) binds to a deprotonated form of the
1,2-dioxohydrazine moiety of Agly peptides 1–5a only and that
no deprotonated peptide bonds participate in the ligand shell of
Cu(II), there is place for the imidazole ring of His residue to bind
Cu(II) and stabilize the Cu(II)–Agly peptide complex (complex
16, Scheme 4). The conformational constrains imposed at the
Agly moiety in complex 14 or 15 are expected to disfavor the
participation of neighboring His residues as observed in this work
and might explain the long-range effect of His residue on the rate
of cleavage. The next step is the oxidation of the hydrazo moiety
by Cu(II), which has been demonstrated to generate Cu(I) species
(Figure 4). Formation of isocyanate 18 is proposed based on the
study of Heyman et al. [29]. In this report, the oxidation of alkyl
semicarbazides with CuCl2 was shown to produce isocyanates by
the elimination of the diazene group. Hydrolysis or cyclization of
isocyanate 18isexpectedtoyieldpeptides11and12, respectively,
whereas hydrolysis of diazene 17 is expected to produce peptide
10.
13 Liley M, Johnson T. Solid phase synthesis of azapeptides utilising
reversible amide bond protection to prevent hydantoin formation.
Tetrahedron Lett. 2000; 41: 3983–3985.
14 Melendez RE,Lubell WD.Aza-aminoacidscanforrapididentification
of secondary structure based on the application of N-Boc-aza(1)-
dipeptides in peptide synthesis. J. Am. Chem. Soc. 2004; 126:
6759–6764.
15 Boeglin D, Lubell WD. Aza-amino acid scanning of secondary
structure suited for solid-phase peptide synthesis with fmoc
chemistry and aza-amino acids with heteroatomic side chains. J.
Comb. Chem. 2005; 7: 864–878.
In conclusion, we show that Cu(II) but not other metal ions
such as Fe(II), Fe(III), Pd(II), or Pt(II) induces the cleavage of Agly
peptides at room temperature and pH 7.3. The cleavage occurs
in the absence of an anchoring His residue within the peptide
but it is accelerated when this amino acid is present in the
sequence. The distance between the His and Agly residues has an
important impact on the rate of cleavage. The highest rates were
observed for His residues distant from Agly moiety. The reaction
between Cu(II) and Agly peptides leads to the formation of Cu(I)
c